1. Home
  2. FKWL vs ATOS Comparison

FKWL vs ATOS Comparison

Compare FKWL & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

HOLD

Current Price

$3.48

Market Cap

44.7M

Sector

Utilities

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$5.51

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FKWL
ATOS
Founded
1981
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.7M
36.2M
IPO Year
1997
2010

Fundamental Metrics

Financial Performance
Metric
FKWL
ATOS
Price
$3.48
$5.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$23.00
AVG Volume (30 Days)
7.9K
53.5K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
1.10%
N/A
EPS Growth
94.12
N/A
EPS
0.10
N/A
Revenue
$46,086,901.00
$1,758.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.14
N/A
P/E Ratio
$34.80
N/A
Revenue Growth
49.65
N/A
52 Week Low
$3.41
$0.53
52 Week High
$5.48
$7.56

Technical Indicators

Market Signals
Indicator
FKWL
ATOS
Relative Strength Index (RSI) 35.28 51.26
Support Level N/A $5.16
Resistance Level $4.47 $5.56
Average True Range (ATR) 0.08 0.39
MACD -0.02 -0.03
Stochastic Oscillator 5.26 33.54

Price Performance

Historical Comparison
FKWL
ATOS

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: